(NASDAQ: SNTI) Senti Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 23.92%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.73%.
Senti Biosciences's earnings in 2025 is -$54,791,000.On average, 1 Wall Street analyst forecast SNTI's earnings for 2025 to be -$61,029,865, with the lowest SNTI earnings forecast at -$61,029,865, and the highest SNTI earnings forecast at -$61,029,865.
In 2026, SNTI is forecast to generate -$32,340,612 in earnings, with the lowest earnings forecast at -$32,340,612 and the highest earnings forecast at -$32,340,612.